board of directors
- management team
- board of directors
- founders
- investors
Robert Connelly Chief Executive Officer
David A. Edwards, Ph.D. Professor of Biomedical Engineering, Harvard University
Mark J. Gabrielson President & Chief Executive Officer, Ore Pharmaceutical Holdings Inc. (NASD: ORXE)
Mark J. Gabrielson has been a member of the Ore Board of Directors since 2007, and recently has served as Chairman of the Audit Committee of the Board. Prior to assuming the role of CEO at Ore, he was Managing General Partner of p-Value Capital LLC, a financial services firm focused on investments in biopharmaceutical products. Mark was co-founder and CEO of Pulmatrix Inc. a private venture capital-backed company he launched in 2003 with scientists from Harvard University and MIT that is developing products for respiratory infectious diseases. He is currently on the Board of Directors at Pulmatrix. From 1990 until 2003 Mark was a venture capitalist. He was a General Partner of Prince Ventures, a life sciences focused venture capital firm. The firm’s portfolio included Genentech, Applied Biosystems, Centocor, Regeneron, Inhale Therapeutic Systems and other noteworthy companies. Mark began his career in 1978 at SmithKline Corporation (now GSK) in product management, business development and general management. He was educated at Princeton University.
Steven Gillis, Ph.D. Managing Director, ARCH Venture Partners
Terry McGuire Co-Founder and Managing Partner, Polaris Venture Partners
Scott Rocklage, Ph.D. Managing Partner, 5AM Ventures
Lauren Silverman, Ph.D. Managing Director, Novartis Option Fund